Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-5908
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework ; volume:7 ; number:1 ; day:18 ; month:3 ; year:2012 ; pages:1-8 ; date:12.2012
Implementation science ; 7, Heft 1 (18.3.2012), 1-8, 12.2012
- Urheber
-
Mori, Amani Thomas
- Beteiligte Personen und Organisationen
-
Kaale, Eliangiringa Amos
SpringerLink (Online service)
- DOI
-
10.1186/1748-5908-7-18
- URN
-
urn:nbn:de:1111-2016070921607
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mori, Amani Thomas
- Kaale, Eliangiringa Amos
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up